Sentnel Node
Sentinel Node
Metastasis Risk

This prediction tool is intended to guide informed discussion about treatment between clinicians and their patients.

The data that underpin this risk prediction tool are published in Journal of Clinical of Oncology (view references.)

Acknowledgements :

• The Australian Medical Research Future Fund and Sydney Health Partners • The Australian National Health and Medical Research Council • The Cameron family for their generous support of clinical research data collection at Melanoma Institute Australia • Colleagues at Melanoma Institute Australia and the Royal Prince Alfred, Westmead and Royal North Shore Hospitals, Sydney • Melanoma Institute Australia‚Äôs generous donors and partners • Cancer Institute New South Wales • The Medical Foundation of The University of Sydney • Colleagues from the University of Texas MD Anderson Cancer Center • Melanoma patients and the public who allowed their data to be used to develop and validate these melanoma risk tools • Researchers and participants from the Australian Melanoma Family Study and GEM study • The University of Sydney • The Sydney Local Health District • New South Wales Health Pathology